Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Berdel

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Progress in Clinical and Biological Research|January 1, 1983
Generation of tumorcidal macrophages and direct selective destruction of tumor cells by membrane active adjuvantsP G Munder, M Modolell, R Andreesen, et al.
Onkologie|June 1, 1990
Pirarubicin in advanced non-small cell lung cancer. A trial of the Phase I/II Study Group of the Association for Medical Oncology of the German Cancer SocietyP Drings, I U Günther, U Gatzemeier, et al.
International Journal of Oncology|May 14, 2011
Interleukin-1 receptor antagonist inhibits growth modulation of human tumor-cell lines by interleukin-1 in-vitroE Oelmann, M Topp, B Reufi, et al.
International Journal of Oncology|May 17, 2011
Mutation and expression of the p53 tumor suppressor gene in tumor samples and cancer cell-lines - comparison of nonisotopic direct DNA-sequencing, immunoblotting and immunohistochemistryP Lang, J Maurer, D Hoher, et al.
International Journal of Oncology|May 17, 2011
Urokinase-type plasminogen-activator (upa), a protease with cytokine-like activity in human hl-60 leukemic-cell lineW Berdel, O Wilhelm, M Schmitt, et al.
International Journal of Oncology|May 5, 2011
Fresh peripheral blood mononuclear cell preparations are a better starting material than bone marrow after cryopreservation for immunomagnetic harvesting of CD34(+) hematopoietic cellsC Papadimitriou, A Roots, M Koenigsmann, et al.
Annals of Hematology|May 6, 2004
Risk-adapted therapy of AML: the AMLCG experienceW Kern, T Haferlach, C Schoch, et al.
International Journal of Oncology|May 5, 2011
Phase II pilot trial of preoperative high-dose chemotherapy in patients with malignant tumors of the upper gastrointestinal tractW Berdel, T Heldmann, C Germer, et al.
Journal of Perinatal Medicine|January 1, 1996
Successful emergency splenectomy during pregnancy in a patient with life-threatening idiopathic thrombocytopenia. Case reportB Stiemer, F Opri, D Senger, et al.
International Journal of Oncology|May 17, 2011
Interleukin-4 inhibits growth of a human lung-tumor cell-line in-vitro and has therapeutic activity against xenografts of this cell-line in-vivoM Topp, M Koenigsmann, A Miresluis, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Progress in Clinical and Biological Research|January 1, 1983
Generation of tumorcidal macrophages and direct selective destruction of tumor cells by membrane active adjuvantsP G Munder, M Modolell, R Andreesen, et al.
Onkologie|June 1, 1990
Pirarubicin in advanced non-small cell lung cancer. A trial of the Phase I/II Study Group of the Association for Medical Oncology of the German Cancer SocietyP Drings, I U Günther, U Gatzemeier, et al.
International Journal of Oncology|May 14, 2011
Interleukin-1 receptor antagonist inhibits growth modulation of human tumor-cell lines by interleukin-1 in-vitroE Oelmann, M Topp, B Reufi, et al.
International Journal of Oncology|May 17, 2011
Mutation and expression of the p53 tumor suppressor gene in tumor samples and cancer cell-lines - comparison of nonisotopic direct DNA-sequencing, immunoblotting and immunohistochemistryP Lang, J Maurer, D Hoher, et al.
International Journal of Oncology|May 17, 2011
Urokinase-type plasminogen-activator (upa), a protease with cytokine-like activity in human hl-60 leukemic-cell lineW Berdel, O Wilhelm, M Schmitt, et al.
International Journal of Oncology|May 5, 2011
Fresh peripheral blood mononuclear cell preparations are a better starting material than bone marrow after cryopreservation for immunomagnetic harvesting of CD34(+) hematopoietic cellsC Papadimitriou, A Roots, M Koenigsmann, et al.
Annals of Hematology|May 6, 2004
Risk-adapted therapy of AML: the AMLCG experienceW Kern, T Haferlach, C Schoch, et al.
International Journal of Oncology|May 5, 2011
Phase II pilot trial of preoperative high-dose chemotherapy in patients with malignant tumors of the upper gastrointestinal tractW Berdel, T Heldmann, C Germer, et al.
Journal of Perinatal Medicine|January 1, 1996
Successful emergency splenectomy during pregnancy in a patient with life-threatening idiopathic thrombocytopenia. Case reportB Stiemer, F Opri, D Senger, et al.
International Journal of Oncology|May 17, 2011
Interleukin-4 inhibits growth of a human lung-tumor cell-line in-vitro and has therapeutic activity against xenografts of this cell-line in-vivoM Topp, M Koenigsmann, A Miresluis, et al.
Pageof 3